Steve E. Krognes
Director · 9 filings · Latest: Jun 17, 2026
Denali Therapeutics Inc.
Guardant Health, Inc.
PLIANT THERAPEUTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
GH | Steve E. Krognes | Director | Jun 17, 2026 | Option Exercise | $0.00 | 4,203 | — | 14,425 | |
GH | Steve E. Krognes | Director | Jun 4, 2026 | Sale | $132.51 | 9,294 | $1.2M | 10,222 | |
GH | Krognes Steve E. | — | Jun 4, 2026 | Proposed Sale | $132.51 | 9,294 | $1.2M | — | |
GH | Steve E. Krognes | Director | May 31, 2026 | Option Exercise | $0.00 | 154 | — | 19,516 | |
GH | Steve E. Krognes | Director | Apr 30, 2026 | Option Exercise | $0.00 | 154 | — | 19,362 | |
GH | Steve E. Krognes | Director | Mar 31, 2026 | Option Exercise | $0.00 | 155 | — | 19,208 | |
GH | Steve E. Krognes | Director | Feb 28, 2026 | Option Exercise | $0.00 | 154 | — | 19,053 | |
GH | Steve E. Krognes | Director | Jan 31, 2026 | Option Exercise | $0.00 | 154 | — | 18,899 | |
DNLI | Krognes Steve E. | — | Jan 7, 2025 | Proposed Sale | $20.81 | 3,339 | $69.5K | — | |
DNLI | STEVE KROGNES | — | Dec 31, 2024 | Proposed Sale | $20.24 | 30,000 | $607.2K | — | |
DNLI | STEVE KROGNES | — | Sep 30, 2024 | Proposed Sale | $29.43 | 30,000 | $882.9K | — |